ASK REDCHAT ANYTHING ABOUT PHATHOM PHARMACEUTICALS, INC.
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT)
Listen to this Section
$9.90
-0.1900
(
-1.88% )
525.7K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| VOQUEZNA (Vonoprazan)(Potassium competitive acid blocker)DetailsIntestinal infection, Gastroesophageal reflux disease, Esophagitis |
Approved |
| VOQUEZNA® (vonoprazan)(potassium competitive acid blocker)DetailsGastroesophageal reflux disease |
Phase 3 |
| VOQUEZNA (Vonoprazan) (Potassium competitive acid blocker)DetailsBacterial infection |
Approved |
| VOQUEZNA® (Vonoprazan)(potassium competitive acid blocker)DetailsEosinophilic Esophagitis |
Phase 2 |
Market Data
|
| Open |
$9.90 |
| Previous Close |
$10.09 |
| Volume |
525.7K |
| Market Cap |
$804.74M |
| Day Range |
$9.77 - $10.45 |
| 52 Week Range |
$4.47 - $18.31 |
| Shares Outstanding |
79.76M |
| Change % |
-1.88% |
| Net Change |
▼ -0.1900 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Year | 2019 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-4,525,721.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-05-23 |
Buy |
3780.00 |
Topper James N |
| 2025-05-15 |
Buy |
1120.00 |
Topper James N |
| 2025-05-13 |
Buy |
33376.00 |
Topper James N |
| 2025-05-08 |
Buy |
5000.00 |
Parikh Asit |
| 2024-12-16 |
Buy |
12500.00 |
KARBE FRANK |
| 2024-12-16 |
Buy |
10000.00 |
Parikh Asit |
| 2024-07-17 |
Sale |
-4325.00 |
Henderson Molly |
| 2024-07-17 |
Sale |
-33848.00 |
Curran Terrie |
| 2024-07-17 |
Sale |
-10901.00 |
Nabulsi Azmi |
| 2024-05-31 |
Sale |
-25000.00 |
KARBE FRANK |